Activation of Epidermal Toll-Like Receptor 2 Enhances Tight Junction Function: Implications for Atopic Dermatitis and Skin Barrier Repair  I-Hsin Kuo,

Slides:



Advertisements
Similar presentations
Volume 24, Issue 3, Pages (March 2006)
Advertisements

The Tumor Necrosis Factor Superfamily Molecule LIGHT Promotes Keratinocyte Activity and Skin Fibrosis  Rana Herro, Ricardo Da S. Antunes, Amelia R. Aguilera,
IL-1β–Induced Protection of Keratinocytes against Staphylococcus aureus-Secreted Proteases Is Mediated by Human β-Defensin 2  Bingjie Wang, Brian J. McHugh,
Characterization of Spink6 in Mouse Skin: The Conserved Inhibitor of Kallikrein-Related Peptidases Is Reduced by Barrier Injury  Jan Fischer, Zhihong.
Interleukin-10 Downregulates Anti-Microbial Peptide Expression in Atopic Dermatitis  Michael D. Howell, Natalija Novak, Thomas Bieber, Saveria Pastore,
Growth Retardation, Loss of Desmosomal Adhesion, and Impaired Tight Junction Function Identify a Unique Role of Plakophilin 1 In Vivo  Katrin Rietscher,
Andrew W. Borkowski, I-Hsin Kuo, Jamie J
Cathelicidin Antimicrobial Peptide LL-37 in Psoriasis Enables Keratinocyte Reactivity against TLR9 Ligands  Shin Morizane, Kenshi Yamasaki, Beda Mühleisen,
CD44 Regulates Tight-Junction Assembly and Barrier Function
Staphylococcus aureus Stimulates Neutrophil Targeting Chemokine Expression in Keratinocytes through an Autocrine IL-1α Signaling Loop  Florina Olaru,
Activation of protease-activated receptor 2 leads to impairment of keratinocyte tight junction integrity  Peter Nadeau, BS, Mason Henehan, BS, Anna De.
A Toll-Like Receptor 7, 8, and 9 Antagonist Inhibits Th1 and Th17 Responses and Inflammasome Activation in a Model of IL-23-Induced Psoriasis  Weiwen.
P300 Is Elevated in Systemic Sclerosis and Its Expression Is Positively Regulated by TGF-β: Epigenetic Feed-Forward Amplification of Fibrosis  Asish K.
Thrombomodulin Promotes Diabetic Wound Healing by Regulating Toll-Like Receptor 4 Expression  Tsung-Lin Cheng, Chao-Han Lai, Po-Ku Chen, Chia-Fong Cho,
Type I IL-1 Receptor Mediates IL-1 and Intracellular IL-1 Receptor Antagonist Effects in Skin Inflammation  Gaby Palmer, Dominique Talabot-Ayer, Gürkan.
Inhibition of UVB-Induced Skin Tumor Development by Drinking Green Tea Polyphenols Is Mediated Through DNA Repair and Subsequent Inhibition of Inflammation 
Trim32 Deficiency Enhances Th2 Immunity and Predisposes to Features of Atopic Dermatitis  Yuangang Liu, Zhiping Wang, Rachel De La Torre, Ashley Barling,
Decreased Expression of Caveolin-1 Contributes to the Pathogenesis of Psoriasiform Dermatitis in Mice  Yukie Yamaguchi, Yuko Watanabe, Tomoya Watanabe,
IL-1β–Induced Protection of Keratinocytes against Staphylococcus aureus-Secreted Proteases Is Mediated by Human β-Defensin 2  Bingjie Wang, Brian J. McHugh,
Increased ICAM-1 Expression Causes Endothelial Cell Leakiness, Cytoskeletal Reorganization and Junctional Alterations  Paul R. Clark, Thomas D. Manes,
Alteration of the EphA2/Ephrin-A Signaling Axis in Psoriatic Epidermis
Vaccinia Virus Binds to the Scavenger Receptor MARCO on the Surface of Keratinocytes  Daniel T. MacLeod, Teruaki Nakatsuji, Zhenping Wang, Anna di Nardo,
Polyinosinic:polycytidylic acid induces protein kinase D–dependent disassembly of apical junctions and barrier dysfunction in airway epithelial cells 
Localization, Age- and Site-Dependent Expression, and Regulation of 11β- Hydroxysteroid Dehydrogenase Type 1 in Skin  Ana Tiganescu, Elizabeth A. Walker,
Histamine Contributes to Tissue Remodeling via Periostin Expression
Th17 Cytokines Stimulate CCL20 Expression in Keratinocytes In Vitro and In Vivo: Implications for Psoriasis Pathogenesis  Erin G. Harper, Changsheng Guo,
Staphylococcus aureus Exploits Epidermal Barrier Defects in Atopic Dermatitis to Trigger Cytokine Expression  Teruaki Nakatsuji, Tiffany H. Chen, Aimee.
Staphylococcal LTA-Induced miR-143 Inhibits Propionibacterium acnes-Mediated Inflammatory Response in Skin  Xiaoli Xia, Zhiheng Li, Kewei Liu, Yelin Wu,
Activation of TLR2 by a Small Molecule Produced by Staphylococcus epidermidis Increases Antimicrobial Defense against Bacterial Skin Infections  Yuping.
Topically Applied Flightless I Neutralizing Antibodies Improve Healing of Blistered Skin in a Murine Model of Epidermolysis Bullosa Acquisita  Zlatko.
IL-1R1 Signaling Facilitates Munro’s Microabscess Formation in Psoriasiform Imiquimod-Induced Skin Inflammation  Mireia Uribe-Herranz, Li-Hua Lian, Kirsten.
IL-36γ Induced by the TLR3-SLUG-VDR Axis Promotes Wound Healing via REG3A  Ziwei Jiang, Yuanqi Liu, Changwei Li, Leilei Chang, Wang Wang, Zhenhua Wang,
Regulation of IL-33 Expression by IFN-γ and Tumor Necrosis Factor-α in Normal Human Epidermal Keratinocytes  Jitlada Meephansan, Hidetoshi Tsuda, Mayumi.
Abnormally Differentiating Keratinocytes in the Epidermis of Systemic Sclerosis Patients Show Enhanced Secretion of CCN2 and S100A9  Joanna Nikitorowicz-Buniak,
IL-18, but Not IL-12, Induces Production of IFN-γ in the Immunosuppressive Environment of HPV16 E7 Transgenic Hyperplastic Skin  Christina Gosmann, Ian.
The Antimicrobial Heterodimer S100A8/S100A9 (Calprotectin) Is Upregulated by Bacterial Flagellin in Human Epidermal Keratinocytes  Arby Abtin, Leopold.
Abnormally Differentiating Keratinocytes in the Epidermis of Systemic Sclerosis Patients Show Enhanced Secretion of CCN2 and S100A9  Joanna Nikitorowicz-Buniak,
Histone Acetylation in Keratinocytes Enables Control of the Expression of Cathelicidin and CD14 by 1,25-Dihydroxyvitamin D3  Jürgen Schauber, Yuko Oda,
The Antimicrobial Protein Psoriasin (S100A7) Is Upregulated in Atopic Dermatitis and after Experimental Skin Barrier Disruption  Regine Gläser, Ulf Meyer-Hoffert,
Anti-Inflammatory Activity of Sertaconazole Nitrate Is Mediated via Activation of a p38– COX-2–PGE2 Pathway  Runa Sur, Jeffrey M. Babad, Michelle Garay,
Reductions in claudin-1 may enhance susceptibility to herpes simplex virus 1 infections in atopic dermatitis  Anna De Benedetto, MD, Mark K. Slifka, PhD,
Histamine H1 and H2 Receptor Antagonists Accelerate Skin Barrier Repair and Prevent Epidermal Hyperplasia Induced by Barrier Disruption in a Dry Environment 
S100A15, an Antimicrobial Protein of the Skin: Regulation by E
Vitamin D Analog Calcipotriol Suppresses the Th17 Cytokine–Induced Proinflammatory S100 “Alarmins” Psoriasin (S100A7) and Koebnerisin (S100A15) in Psoriasis 
Discoidin Domain Receptor 2–microRNA 196a–Mediated Negative Feedback against Excess Type I Collagen Expression Is Impaired in Scleroderma Dermal Fibroblasts 
Anne T. Funding, Claus Johansen, Matthias Gaestel, Bo M
Biopositive Effects of Low-Dose UVB on Epidermis: Coordinate Upregulation of Antimicrobial Peptides and Permeability Barrier Reinforcement  Seung P. Hong,
IL-22 Promotes Fibroblast-Mediated Wound Repair in the Skin
Poly(I:C) Drives Type I IFN- and TGFβ-Mediated Inflammation and Dermal Fibrosis Simulating Altered Gene Expression in Systemic Sclerosis  Giuseppina A.
Inter-Regulation of Th17 Cytokines and the IL-36 Cytokines In Vitro and In Vivo: Implications in Psoriasis Pathogenesis  Yijun Carrier, Hak-Ling Ma, Hilda.
Localization of Serine Racemase and Its Role in the Skin
Wound Healing Is Defective in Mice Lacking Tetraspanin CD151
Genetic Variants in Interferon Regulatory Factor 2 (IRF2) Are Associated with Atopic Dermatitis and Eczema Herpeticum  Pei-Song Gao, Donald Y.M. Leung,
Retinoid-Induced Epidermal Hyperplasia Is Mediated by Epidermal Growth Factor Receptor Activation Via Specific Induction of its Ligands Heparin-Binding.
Increased Expression of Wnt2 and SFRP4 in Tsk Mouse Skin: Role of Wnt Signaling in Altered Dermal Fibrillin Deposition and Systemic Sclerosis  Julie Bayle,
Th2 Cytokines Suppress Lipoteichoic Acid–Induced Matrix Metalloproteinase Expression and Keratinocyte Migration in Response to Wounding  Anne M. Brauweiler,
IFN-α Enhances IL-22 Receptor Expression in Keratinocytes: A Possible Role in the Development of Psoriasis  Mikiko Tohyama, Lujun Yang, Yasushi Hanakawa,
Collagen Synthesis Is Suppressed in Dermal Fibroblasts by the Human Antimicrobial Peptide LL-37  Hyun Jeong Park, Dae Ho Cho, Hee Jung Kim, Jun Young.
Syed M. Meeran, Thejass Punathil, Santosh K. Katiyar 
Toll-Like Receptor 3 Ligand Polyinosinic:Polycytidylic Acid Promotes Wound Healing in Human and Murine Skin  Qing Lin, Li Wang, Youkun Lin, Xialin Liu,
Pimecrolimus Enhances TLR2/6-Induced Expression of Antimicrobial Peptides in Keratinocytes  Amanda S. Büchau, Jürgen Schauber, Thomas Hultsch, Anton Stuetz,
IL-17A Upregulates Keratin 17 Expression in Keratinocytes through STAT1- and STAT3- Dependent Mechanisms  Xiaowei Shi, Liang Jin, Erle Dang, Ting Chang,
Activation of TLR3 in Keratinocytes Increases Expression of Genes Involved in Formation of the Epidermis, Lipid Accumulation, and Epidermal Organelles 
Eric N. Johnson  Journal of Investigative Dermatology 
Aldo-Keto Reductase 1C3 Is Expressed in Differentiated Human Epidermis, Affects Keratinocyte Differentiation, and Is Upregulated in Atopic Dermatitis 
Andrew W. Borkowski, I-Hsin Kuo, Jamie J
All-Trans Retinoic Acid Antagonizes UV-Induced VEGF Production and Angiogenesis via the Inhibition of ERK Activation in Human Skin Keratinocytes  Mi-Sun.
Volume 24, Issue 3, Pages (March 2006)
Production of the Soluble Form of KIT, s-KIT, Abolishes Stem Cell Factor-Induced Melanogenesis in Human Melanocytes  Shinya Kasamatsu, Akira Hachiya,
The Interleukin-6 Cytokine System Regulates Epidermal Permeability Barrier Homeostasis  Xu-Ping Wang, Michael Schunck, Karl-Josef Kallen, Claudia Neumann,
Presentation transcript:

Activation of Epidermal Toll-Like Receptor 2 Enhances Tight Junction Function: Implications for Atopic Dermatitis and Skin Barrier Repair  I-Hsin Kuo, Amanda Carpenter-Mendini, Takeshi Yoshida, Laura Y. McGirt, Andrei I. Ivanov, Kathleen C. Barnes, Richard L. Gallo, Andrew W. Borkowski, Kenshi Yamasaki, Donald Y. Leung, Steve N. Georas, Anna De Benedetto, Lisa A. Beck  Journal of Investigative Dermatology  Volume 133, Issue 4, Pages 988-998 (April 2013) DOI: 10.1038/jid.2012.437 Copyright © 2013 The Society for Investigative Dermatology, Inc Terms and Conditions

Figure 1 Toll-like receptor 2 (TLR2) agonists enhance tight junction (TJ) function in primary human keratinocytes (PHKs). Transepithelial electrical resistance (TEER) was measured daily until day 8 in PHKs stimulated with (a) Staphylococcus aureus–derived peptidoglycan (PGN, n=3–7), (b) S. aureus–derived lipoteichoic acid (LTA, n=3), (c) Pam3CSK4, a TLR1/2 ligand (n=3–6), (d) Malp-2, a TLR2/6 ligand (n=5), (e) lipopolysaccharide (LPS), a TLR4 ligand (n=3), and (f) polyinosinic-polycytidylic acid (polyI:C), a TLR3 ligand (n=3–9). Malp-2, macrophage-activating lipopeptide-2; Pam3CSK4, N-palmitoyl-S-[2,3-bis(palmitoyl)-(2RS)-propyl]-(R)cysteinyl-alanyl-glycine. Data are presented as the mean±SEM by analyzing the area under the TEER curve normalized to the mean values for the control group (media alone). (g) PHKs grown on Transwell inserts were stimulated with the indicated concentrations of S. aureus–derived PGN, Pam3CSK4, and Malp-2 for 48hours and paracellular flux measured and compared with media alone. Data are expressed as a fold of media alone group; n=3; *P<0.05; **P<0.01; ***P<.001. NS, not significant. Journal of Investigative Dermatology 2013 133, 988-998DOI: (10.1038/jid.2012.437) Copyright © 2013 The Society for Investigative Dermatology, Inc Terms and Conditions

Figure 2 Toll-like receptor 2 (TLR2) agonists induce tight junction (TJ) protein expression and subcellular localization. Primary human keratinocytes (PHKs) were treated with (a) Staphylococcus aureus–derived peptidoglycan (PGN; 0.2, 2, and 20μgml−1), Pam3CSK4 (0.1, 1, and 10μgml−1), Malp-2 (10, 100, and 1,000 ngml−1), and (b) lipoteichoic acid (LTA; 1 and 10μgml−1) for 48hours, and claudin-1 (CLDN1), occludin, Zonulae occludens 1 (ZO-1), and claudin-23 (CLDN23) protein levels were detected from whole-cell lysates by western blot analysis. Malp-2, macrophage-activating lipopeptide-2; Pam3CSK4, N-palmitoyl-S-[2,3-bis(palmitoyl)-(2RS)-propyl]-(R)cysteinyl-alanyl-glycine. Quantitative protein expression was determined by densitometry of bands after normalization to the housekeeping protein (β-actin). (c) Membrane and cytosolic protein lysates were made and TJ proteins were detected by western blot analysis after treating PHKs with PGN (20μgml−1) for 48hours. Representative blot of n=3 experiments. Journal of Investigative Dermatology 2013 133, 988-998DOI: (10.1038/jid.2012.437) Copyright © 2013 The Society for Investigative Dermatology, Inc Terms and Conditions

Figure 3 Toll-like receptor 2 (TLR2)-neutralizing antibody inhibited Staphylococcus aureus–derived peptidoglycan (PGN) effect on tight junction (TJ) protein function and expression. (a) Transepithelial electrical resistance (TEER; n=5) and (b) paracellular flux (n=5) measurement at 48hours (day 2) in primary human keratinocytes (PHKs) treated with PGN (20μgml−1) and/or TLR2-neutralizing antibody (10μgml−1). Data are normalized to the control group (IgG2b treatment). (c) TJ mRNA (n=3) and (d) protein expression (representative blot of n=3 experiments) was observed in response to treatment with PGN (20μgml−1, 24 or 48hours, respectively) with or without TLR2-neutralizing antibody (5μgml−1). The expression was quantified by densitometry of bands and normalization to the housekeeping protein (β-actin). CLDN1, claudin-1; CLDN23, claudin-23; ZO-1, Zonulae occludens 1. *P<0.05; **P<0.01; ***P<0.001; #compared IgG2b+PGN with TLR2Ab+PGN. Journal of Investigative Dermatology 2013 133, 988-998DOI: (10.1038/jid.2012.437) Copyright © 2013 The Society for Investigative Dermatology, Inc Terms and Conditions

Figure 4 Toll-like receptor 2 (TLR2) agonist enhances skin barrier repair. (a) Schema of modified Snapwell system used to measure transepithelial electrical resistance (TEER) and paracellular flux in full-thickness human or mouse epidermis. PBS, phosphate-buffered saline. Epidermal sheets from normal subjects were placed in modified Snapwell following tape stripping and treated with Pam3CSK4 (10μgml−1) for 24hours. (b) TEER (n=7 per group) and (c) paracellular flux (n=3 per group) were measured at 24hours. Pam3CSK4, N-palmitoyl-S-[2,3-bis(palmitoyl)-(2RS)-propyl]-(R)cysteinyl-alanyl-glycine. (d) Transepidermal water loss (TEWL) recovery curve after tape stripping mouse skin (wild type (WT), n=4; Tlr2−/−, n=4; time -1hour=baseline TEWL before tape stripping). (e) TLR2 agonist effect on TEER restoration at 24hours measured by modified Snapwell after murine barrier disruption by tape stripping (WT, n=5; Tlr2−/−, n=5). TEER absolute value at 24hours in control group is 227± 27ohms × cm2 (human epidermis) and 241± 44ohms × cm2 (WT mice epidermis). NS, not significant. *P<0.05; **P<0.01; ***P<0.001. Journal of Investigative Dermatology 2013 133, 988-998DOI: (10.1038/jid.2012.437) Copyright © 2013 The Society for Investigative Dermatology, Inc Terms and Conditions

Figure 5 Reduced mRNA expression of Toll-like receptors 1 and 2 (TLR1 and TLR2) in epidermal sheets from atopic dermatitis (AD) subjects. Nonlesional AD epidermis (n=8) was compared with epidermis from nonatopic healthy control (NA; n=14–15) obtained from the same anatomical location. The relative mRNA expression level was normalized to glyceraldehyde-3-phosphate dehydrogenase (GAPDH; Mann–Whitney t-test). NOD2, nucleotide-binding oligomerization domain-containing 2; PGLYRP-3, peptidoglycan recognition protein 3; PGLYRP-4, peptidoglycan recognition protein 4; RVU, relative value unit. *P<0.05; NS, not significant. Journal of Investigative Dermatology 2013 133, 988-998DOI: (10.1038/jid.2012.437) Copyright © 2013 The Society for Investigative Dermatology, Inc Terms and Conditions

Figure 6 The reduced Toll-like receptor 2 (TLR2) expression observed in atopic dermatitis (AD) epithelium inversely correlates with measures of barrier integrity. (a) Representative paraffin-embedded skin biopsy samples from a nonatopic healthy control (NA; n=10), nonlesional AD (AD_NL; n=13), and lesional AD (AD_L; n=13) subjects stained for TLR2 are shown. The white dotted lines denote the epidermal–dermal junction. Bar=100μm. (b) Epidermal TLR2 staining intensity is shown (Mann–Whitney t-test). (c) The line represents the linear least square fit for TLR2 epidermal staining intensity versus transepidermal water loss (TEWL; Spearman’s nonparametric correlation (n=25); r=-0.654, P=0.0004). *P<0.05; ***P<0.001. Journal of Investigative Dermatology 2013 133, 988-998DOI: (10.1038/jid.2012.437) Copyright © 2013 The Society for Investigative Dermatology, Inc Terms and Conditions